Dr. Ruffolo is the retired President of Research & Development and Corporate Senior Vice President of Wyeth Pharmaceutics (now Pfizer). While at Wyeth, he managed an R&D organization of more than 7,000 scientists, with an annual budget of $3 billion. Prior to joining Wyeth, Dr. Ruffolo spent 17 years at SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) where he was Senior Vice President and Director of Biological Sciences, Worldwide. Before joining SmithKline Beecham, Dr. Ruffolo spent 6 years at Lilly Research Laboratories where he was Chairman of the Cardiovascular Research Committee.
